A meta-analysis demonstrated that patients with MASLD exhibit significantly elevated levels of C-reactive protein (CRP), along with increases in other inflammatory markers, thereby supporting the presence of subclinical inflammation in this patient population [28]. This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.